XML 86 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
Quarterly Financial Information - Statements of Cash Flows (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:                
Net loss       $ (9,995,000) $ (21,481,000) $ (25,412,000) $ (71,067,000) $ (51,853,000)
Adjustments to reconcile net loss to net cash used in operating activities:                
Noncash inventory reserve             5,323,000  
Depreciation       77,000 1,255,000 1,280,000 2,064,000 105,000
Amortization       209,000 188,000 254,000 159,000 171,000
Loss on disposition of assets           11,122,000    
Noncash stock-based compensation       1,418,000 1,969,000 2,493,000 3,338,000 2,818,000
Noncash amortization of deferred financing costs       838,000 1,635,000 1,969,000 1,661,000 1,341,000
Unrealized gain on warrants       (6,890,000) (22,171,000) (25,520,000) (3,827,000)  
Changes in operating assets and liabilities:                
Accounts receivable       (144,000) (2,178,000) (1,844,000) (668,000) (865,000)
Inventory       (1,079,000) (831,000) (366,000) (6,289,000)  
Prepaid expenses and other assets       2,480,000 (1,551,000) 880,000 (967,000) (2,485,000)
Accounts payable and accrued expenses       3,572,000 (2,213,000) (628,000) 5,202,000 3,641,000
Lease liability       (235,000) (132,000) (175,000) (131,000) (184,000)
Net cash used in operating activities       (9,749,000) (34,388,000) (35,947,000) (65,202,000) (47,311,000)
Cash flows from investing activities:                
Purchases of marketable securities               (54,837,000)
Sales and maturities of marketable securities             39,729,000 14,500,000
Acquisition of property and equipment         (133,000) (133,000) (269,000) (353,000)
Net cash provided by investing activities         (133,000) (133,000) 39,460,000 (40,690,000)
Cash flows from financing activities:                
Proceeds from issuance of common stock in public offering, net of offering costs       6,509,000 21,971,000 21,936,000 21,081,000 48,434,000
Proceeds from Issuance of Long-term Debt               20,000,000
Repayments of long-term debt       (675,000) (17,150,000) (17,375,000)    
Debt financing costs paid               (1,059,000)
Proceeds from exercise of stock options             75,000 610,000
Net cash provided by financing activities       7,375,000 21,523,000 22,183,000 30,422,000 67,985,000
Net (decrease) increase in cash and cash equivalents       (2,374,000) (12,998,000) (13,897,000) 4,680,000 (20,016,000)
Cash and cash equivalents, beginning of period   $ 19,143,000 $ 19,143,000 5,246,000 19,143,000 19,143,000 14,463,000 34,479,000
Cash and cash equivalents, end of period $ 6,145,000     2,873,000 6,145,000 5,246,000 19,143,000 14,463,000
Supplemental cash flow information                
Interest paid       276,000 1,078,000 1,162,000 2,383,000 2,099,000
As Previously Reported | Error Correction, Accounting for Warrants                
Cash flows from operating activities:                
Net loss   (11,769,000) (23,988,000)   (43,652,000)   (74,894,000)  
Adjustments to reconcile net loss to net cash used in operating activities:                
Noncash inventory reserve             5,323,000  
Depreciation   527,000 1,057,000   1,255,000   2,064,000  
Amortization   61,000 124,000   188,000   159,000  
Loss on disposition of assets 11,122,000       11,122,000      
Noncash stock-based compensation   764,000 1,433,000   1,969,000   3,338,000  
Noncash amortization of deferred financing costs   419,000 797,000   1,635,000   1,661,000  
Changes in operating assets and liabilities:                
Accounts receivable   (132,000) (554,000)   (2,178,000)   (668,000)  
Income taxes receivable   (4,675,000)            
Inventory   (1,727,000) (1,374,000)   (831,000)   (6,289,000)  
Prepaid expenses and other assets   707,000 1,267,000   (1,551,000)   (967,000)  
Accounts payable and accrued expenses   1,095,000 3,643,000   (2,213,000)   5,202,000  
Lease liability   (21,000) (90,000)   (132,000)   (131,000)  
Net cash used in operating activities   (14,751,000) (17,685,000)   (34,388,000)   (65,202,000)  
Cash flows from investing activities:                
Sales and maturities of marketable securities             39,729,000  
Acquisition of property and equipment   (126,000) (133,000)   (133,000)   (269,000)  
Net cash provided by investing activities   (126,000) (133,000)   (133,000)   39,460,000  
Cash flows from financing activities:                
Proceeds from issuance of common stock in public offering, net of offering costs         21,971,000   21,081,000  
Repayments of long-term debt   (5,000,000) (5,000,000)   (17,150,000)      
Proceeds from exercise of stock options             75,000  
Net cash provided by financing activities   (523,000) 11,702,000   21,523,000   30,422,000  
Net (decrease) increase in cash and cash equivalents   (15,400,000) (6,116,000)   (12,998,000)   4,680,000  
Cash and cash equivalents, beginning of period 13,027,000 19,143,000 19,143,000   19,143,000 19,143,000 14,463,000  
Cash and cash equivalents, end of period 6,145,000 3,743,000 13,027,000   6,145,000   19,143,000 $ 14,463,000
Supplemental cash flow information                
Interest paid   452,000 898,000   1,078,000   2,383,000  
Error Correction, Adjustment | Error Correction, Accounting for Warrants                
Cash flows from operating activities:                
Net loss   1,384,000 8,435,000   22,171,000   3,827,000  
Adjustments to reconcile net loss to net cash used in operating activities:                
Unrealized gain on warrants   (1,384,000) (8,435,000)   (22,171,000)   (3,827,000)  
As Restated                
Cash flows from operating activities:                
Net loss   (10,385,000) (15,553,000)   (21,481,000)      
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation   527,000 1,057,000   1,255,000      
Amortization   61,000 124,000   188,000      
Loss on disposition of assets 11,122,000       11,122,000      
Noncash stock-based compensation   764,000 1,433,000   1,969,000      
Noncash amortization of deferred financing costs   419,000 797,000   1,635,000      
Unrealized gain on warrants   (1,384,000) (8,435,000)   (22,171,000)      
Changes in operating assets and liabilities:                
Accounts receivable   (132,000) (554,000)   (2,178,000)      
Income taxes receivable   (4,675,000)            
Inventory   (1,727,000) (1,374,000)   (831,000)      
Prepaid expenses and other assets   707,000 1,267,000   (1,551,000)      
Accounts payable and accrued expenses   1,095,000 3,643,000   (2,213,000)      
Lease liability   (21,000) (90,000)   (132,000)      
Net cash used in operating activities   (14,751,000) (17,685,000)   (34,388,000)      
Cash flows from investing activities:                
Acquisition of property and equipment   (126,000) (133,000)   (133,000)      
Net cash provided by investing activities   (126,000) (133,000)   (133,000)      
Cash flows from financing activities:                
Proceeds from issuance of common stock in public offering, net of offering costs         21,971,000      
Repayments of long-term debt   (5,000,000) (5,000,000)   (17,150,000)      
Net cash provided by financing activities   (523,000) 11,702,000   21,523,000      
Net (decrease) increase in cash and cash equivalents   (15,400,000) (6,116,000)   (12,998,000)      
Cash and cash equivalents, beginning of period 13,027,000 19,143,000 19,143,000   19,143,000 19,143,000    
Cash and cash equivalents, end of period $ 6,145,000 3,743,000 13,027,000   6,145,000   19,143,000  
Supplemental cash flow information                
Interest paid   452,000 898,000   1,078,000      
Public offering                
Cash flows from financing activities:                
Proceeds from issuance of preferred stock in registered direct offering, net of offering costs         4,129,000 4,128,000    
Public offering | As Previously Reported | Error Correction, Accounting for Warrants                
Cash flows from financing activities:                
Proceeds from issuance of preferred stock in registered direct offering, net of offering costs   4,129,000 4,129,000   4,129,000      
Public offering | As Restated                
Cash flows from financing activities:                
Proceeds from issuance of preferred stock in registered direct offering, net of offering costs   4,129,000 4,129,000   4,129,000      
At-the-market sales                
Cash flows from financing activities:                
Proceeds from At-the-Market sales of common stock, net of offering costs       $ 1,725,000 12,573,000 $ 13,494,000 9,266,000  
At-the-market sales | As Previously Reported | Error Correction, Accounting for Warrants                
Cash flows from financing activities:                
Proceeds from At-the-Market sales of common stock, net of offering costs   348,000 12,573,000   12,573,000   $ 9,266,000  
At-the-market sales | As Restated                
Cash flows from financing activities:                
Proceeds from At-the-Market sales of common stock, net of offering costs   $ 348,000 $ 12,573,000   $ 12,573,000